Azafaros
Azafaros B.V. aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Leiden, Netherlandswww.azafaros.com ↗
Total raised
€157M
€157,496,800
Funding rounds
2
Investors
8
distinct backers
Active since
2020-06
latest 2025-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood59
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood20
base rate 12% (2+ rounds)
- ▲ €100M+ raised
- ▲ 6y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-14 | Series B | €132M | BioGeneration Ventures (BGV),Forbion Growth,Forbion Ventures,Jeito Capital,Pictet Group,Schroders Capital+1 more | View deal → |
| 2020-06-02 | Series A | €25M | Forbion Capital Partners | View deal → |
Investors
8Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- Roivant Sciences€1.2BSwitzerland · Healthtech